Adult-onset idiopathic generalized epilepsy: clinical and behavioral features.
OBJECTIVE
To identify and define clinical and behavioral features of patients with adult-onset idiopathic generalized epilepsy (IGE).


METHODS
We reviewed the charts of 313 IGE patients at the NYU Comprehensive Epilepsy Center over the past 5 years to identify patients with adult onset (18 years old or older). We excluded patients with childhood or adolescent symptoms that suggested absence, myoclonic, or tonic-clonic seizures, as well as those with a history of significant head injury or other known causes of localization-related epilepsy.


RESULTS
Forty-two (13.4%) patients had a clear onset of IGE in adulthood; average age of onset was early 20s (mean, 23.8 years; range, 18-55 years). Twenty-one patients had adult myoclonic epilepsy (AME, 50%), and three had generalized tonic-clonic seizures on awakening (GTCS-A, 7%). More than two thirds (n=30) are well controlled with current antiepileptic drugs (AEDs), and almost 90% are currently employed (n=37). One third were diagnosed and treated for mental disorders, including depression (n=12), anxiety (n=7), obsessive-compulsive personality disorder (n=2), and postictal psychosis (n=1).


CONCLUSIONS
Adult-onset IGE is associated with a good prognosis. An association may exist between psychological disorders, psychotropic medication, and level of seizure control in adults with IGE.
Cutting
S
S
Department of Neurology, New York University School of Medicine, New York, New York, USA.
Lauchheimer
A
A
Barr
W
W
Devinsky
O
O
D000293:Adolescent; D000328:Adult; D017668:Age of Onset; D002940:Circadian Rhythm / Q000502:physiology; D004569:Electroencephalography / Q000706:statistics & numerical data; D004831:Epilepsies, Myoclonic / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology; D004829:Epilepsy, Generalized / Q000175:diagnosis* / Q000188:drug therapy / Q000523:psychology; D005260:Female; D006801:Humans; D008499:Medical Records; D008875:Middle Aged; D009483:Neuropsychological Tests / Q000706:statistics & numerical data; D011379:Prognosis; D011619:Psychotropic Drugs / Q000627:therapeutic use; D016896:Treatment Outcome
D011619:Psychotropic Drugs